PEXMETINIB Drug Record

  • PEXMETINIB chembl:CHEMBL3545297

    Alternate Names:

    ARRY-614
    PEXMETINIB

    Drug Info:

    FDA Approval not approved
    Drug Class Small molecule
    Drug Indications for treatment of myelodysplastic syndrome
    (0 More Sources)

    Publications:

  • PEXMETINIB   TEK

    Interaction Score: 1.04

    Interaction Types & Directionality:
    inhibitor (inhibitory)

    Interaction Info:
    Mechanism of Interaction Tyrosine-protein kinase TIE-2 inhibitor
    Direct Interaction yes
    Trial Name ARRY-614

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial ChemblInteractions

  • PEXMETINIB   MAPK13

    Interaction Score: 0.38

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Trial Name ARRY-614
    Novel drug target Novel Target

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial

  • PEXMETINIB   MAPK11

    Interaction Score: 0.38

    Interaction Types & Directionality:
    inhibitor (inhibitory)

    Interaction Info:
    Trial Name ARRY-614
    Novel drug target Novel Target

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial

  • PEXMETINIB   MAPK12

    Interaction Score: 0.34

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Trial Name ARRY-614
    Novel drug target Novel Target

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial

  • PEXMETINIB   MAPK14

    Interaction Score: 0.25

    Interaction Types & Directionality:
    inhibitor (inhibitory)

    Interaction Info:
    Trial Name ARRY-614
    Novel drug target Novel Target
    Mechanism of Interaction MAP kinase p38 alpha inhibitor

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial ChemblInteractions

  • PEXMETINIB   ABL1

    Interaction Score: 0.14

    Interaction Types & Directionality:
    inhibitor (inhibitory)

    Interaction Info:
    Trial Name ARRY-614
    Novel drug target Established target

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial

  • PEXMETINIB   KDR

    Interaction Score: 0.07

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Trial Name ARRY-614
    Novel drug target Established target

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial